LEONARD JOHN M Insider Trading Activity

Also formerly known as LEONARD JOHN M.
Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
28
Insider Sells Sum
$83.14M

Insider Activity of LEONARD JOHN M

According to the SEC Form 4 filings, LEONARD JOHN M, being in a position of

  1. President and CEO at Intellia Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 153967 shares for $1.55M,
    over all time since 2018-05-14, has bought 0 shares, and sold 1288512 shares for $76.36M.

Biography of LEONARD JOHN M

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $1,545,5985100

Comparison of Insiders on Amount of Buys and Sells

2026-11-02SaleIntellia Therapeutics, Inc.
NTLA
President and CEO
9,000
0.0069%
$11.99$107,910-1.08%
2026-08-21SaleIntellia Therapeutics, Inc.
NTLA
President and CEO
2,785
0.0021%
$13.00$36,205-4.91%
2026-08-20SaleIntellia Therapeutics, Inc.
NTLA
President and CEO
19,890
0.0151%
$12.60$250,614-1.81%
2026-01-05SaleIntellia Therapeutics, Inc.
NTLA
President and CEO
34,146
0.032%
$9.21$314,485+36.93%
2025-12-11SaleIntellia Therapeutics, Inc.
NTLA
President and CEO
88,146
0.0835%
$9.49$836,384+33.35%
2025-01-03SaleIntellia Therapeutics, Inc.
NTLA
President and CEO
26,807
0.0263%
$12.18$326,509-19.95%
2024-01-03SaleIntellia Therapeutics, Inc.
NTLA
President and CEO
19,223
0.0215%
$29.46$566,310-22.09%
2023-01-04SaleIntellia Therapeutics, Inc.
NTLA
President and CEO
6,673
0.0072%
$37.21$248,302-3.42%
2022-01-01SaleIntellia Therapeutics, Inc.
NTLA
President and CEO
2,493
0.0032%
$112.25$279,852-50.72%
2021-09-01SaleIntellia Therapeutics, Inc.
NTLA
President and CEO
44,735
0.0629%
$170.00$7.6M-53.54%
2021-08-31SaleIntellia Therapeutics, Inc.
NTLA
President and CEO
37,833
0.0496%
$155.00$5.86M-51.39%
2021-08-30SaleIntellia Therapeutics, Inc.
NTLA
President and CEO
38,804
0.0533%
$155.95$6.05M-48.07%
2021-08-23SaleIntellia Therapeutics, Inc.
NTLA
President and CEO
27,139
0.0354%
$152.01$4.13M-46.9%
2021-08-19SaleIntellia Therapeutics, Inc.
NTLA
President and CEO
22,682
0.0323%
$151.28$3.43M-41.29%
2021-04-01SaleIntellia Therapeutics, Inc.
NTLA
President and CEO
76,418
0.1171%
$83.64$6.39M+41.31%
2021-02-09SaleIntellia Therapeutics, Inc.
NTLA
President and CEO
56,086
0.0855%
$75.00$4.21M+54.44%
2021-02-05SaleIntellia Therapeutics, Inc.
NTLA
President and CEO
45,884
0.0668%
$67.66$3.1M+63.76%
2021-02-03SaleIntellia Therapeutics, Inc.
NTLA
President and CEO
135,712
0.22%
$72.54$9.84M+69.86%
2021-02-01SaleIntellia Therapeutics, Inc.
NTLA
President and CEO
219,778
0.3264%
$64.00$14.07M+76.35%
2021-01-05SaleIntellia Therapeutics, Inc.
NTLA
President and CEO
12,478
0.017%
$55.86$697,021+85.43%
Total: 33
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.